Abstract:Yun Fu, Xiaoyin Sun, Zhangyuan Gu, Zhigang Zhuang Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China Correspondence: Zhigang Zhuang Shanghai First Maternity and Infant Hospital, No. 2699, West Gaoke Road, Shanghai 201204, People's Republic of China Tel +86 21 20261056 Fax +86 21 20261477 Email zhuang_zg@163.com Background: Triple-negative breast cancer has become an intricate part and hotspot in the clinical and experimental research. Connexins, serving as functional proteins in gap junctions, play an important role in tumorigenesis, cell proliferation and metastasis. Methods: We constructed and employed the Connexin 43 (Cx43) overexpression lentiviral vectors and Cx43 siRNA in paclitaxel-treated MDA-MB-231 cells. We performed the experiments of clonal formation and flow cytometry to gauge the effect of paclitaxel on cellular behaviors and immunofluorescence and subsequent quantitative RT-PCR and Western blot to examine the expression of genes and corresponding proteins. Experiments of scrape loading/dye transfer were utilized to explore the gap junctions. The targets of Cx43 were identified via the experiments of co-immunoprecipitation (Co-IP), GST pull-down assays and proximal ligation assay (PLA). Results: The results showed that Cx43 hindered cell proliferation and promoted apoptosis in the paclitaxel-treated MDA-MB-231 cells. Overexpressed Cx43 suppressed the expression of resistance genes such as BRCP, Txr-1, α-tubulin and β-tubulin and promoted the expression of apoptosis gene as TSP-1 and Bcl-2. Cx43 was also positively related to ITGα 9 and negatively related to ITGαV and ITGα 11. The gap junctions altered magnificently under different expressions of Cx43, which indicated that Cx43 could promote the number of intercellular gap junctions. The immunofluorescent experiment revealed that both of Cx43 and β-tubulin were mainly localized in the cytoplasm. The assays of Co-IP and GST pull-down demonstrated that there existed a direct interaction between Cx43 and β-tubulin. Furthermore, the result of PLA also showed that Cx43 interacts with β-tubulin in MDA-MB-231 cells. Conclusion: Overexpression of Cx43 could modulate the cellular resistance to paclitaxel via targeting β-tubulin in triple-negative breast cancer. Keywords: Cx43, β-tubulin, paclitaxel, chemoresistance, gap junctions

ZBTB5 enhances the resistance of cervical cancer to paclitaxel by regulating BCL6

Knockdown of ZBTB11 Impedes R‐loop Elimination and Increases the Sensitivity to Cisplatin by Inhibiting DDX1 Transcription in Bladder Cancer

Down-regulation of UTP23 Promotes Paclitaxel Resistance and Predicts Poorer Prognosis in Ovarian Cancer.

ZBTB28 Induces Autophagy by Regulation of FIP200 and Bcl-XL Facilitating Cervical Cancer Cell Apoptosis

B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.

Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.

Data from B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer

Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting -Tubulin in Triple-Negative Breast Cancer

ZEB1 Confers Chemotherapeutic Resistance to Breast Cancer by Activating ATM

Increased LZTS1 Expression is Associated with a Good Response to Paclitaxel-Based Chemotherapy in Breast Cancer.

N6-methyladenosine modification of linc-OIP5 confers paclitaxel resistance in breast cancer through a DDX5-dependent mechanism

Knockdown of ZBTB7A Inhibits Cell Proliferation of Breast Cancer Through Regulating the Ubiquitination of Estrogen Receptor Alpha.

Exploring the Mechanism of Paclitaxel Inhibiting T-cell Lymphoma Based on High-throughput Sequencing and Public Databases

B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells

Transcriptome Profiling Reveals Inhibitory Effect of Down-regulated ZBTB38 gene on the Transcriptional Regulation of Tumor Cells Proliferation

The Role of CYP1B1 in Paclitaxel Resistance in Breast Cancer

Long Non-Coding RNA TCL6 Enhances Preferential Toxicity of Paclitaxel to Renal Cell Carcinoma Cells.

BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27

miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression

End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability